Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Diclofenac (ATC-Code nach WHO: D11AX18)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2027
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-31
TEN
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-21 - Sofosbuvir, Velpatasvir, Voxilaprevir (Wirkstoffkombination)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Naproxen/Esomeprazol (ATC-Code nach WHO: M01AE52)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2027
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-31
TEN
Netherlands – Business services: law, marketing, consulting, recruitment, printing and security – DAS Inhuur
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Alitretinoin (ATC-Code nach WHO: D11AH04)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2027
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-31
Space critical EEE components for EU non-dependence
ec.europa.eu
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic autonomy by reducing no...
Research FundingCash GrantEuropeOpen
AmountExpected EU contribution: 250,000 EUR - 300,000 EUR
DeadlineSep 2, 2027
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic autonomy by reducing non-EU dependencies on critical space EEE components and related technologies across their entire supply chain;Providing unrestricted access to critical space EEE components and related technologies relevant for EU space missions;Developing or regaining capacity to operate independently in space by developing resilient space EEE components and related technologies supply chains, relying on EU supply chains and/or trustable and reliable supply chains not affected by non-EU export restrictions;Enhancing competitiveness by developing products and capabilities reaching equivalent or superior performance level than those from outside the EU and compete at worldwide level;Opening new opportunities for manufacturers by reducing dependency on non-EU...
RES
Quantum Space Gravimetry topic
ec.europa.eu
Expected Outcome:Projects are expected to contribute to the following outcomes:Support the EU space policy by fostering the development of groundbreak...
Research FundingCash GrantEuropeOpen
AmountExpected EU contribution: 14,000,000 EUR - 15,000,000 EUR
DeadlineSep 2, 2027
Expected Outcome:Projects are expected to contribute to the following outcomes:Support the EU space policy by fostering the development of groundbreaking space technology and support the Quantum Europe Strategy.Enhance the technological maturation of the critical components necessary to perform quantum space gravimetry.Foster the technological leadership and non-dependence of the EU in the field of quantum gravimetry from space and promote the EU’s competitiveness in quantum technologies. This action aims at supporting the maturation, development and/or implementation of quantum gravimetry technology for space. Monitoring the Earth gravity field provides key information and data on Earth mass movements. This type of data is of utmost importance for Earth science and used in many areas, for example to monitor ice sheet changes, floods or droughts, volcanic activities and earthquakes. The...
RES
Space critical equipment for EU non-dependence
ec.europa.eu
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic autonomy by reducing no...
Research FundingCash GrantEuropeOpen
AmountExpected EU contribution: 250,000 EUR - 300,000 EUR
DeadlineSep 2, 2027
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic autonomy by reducing non-EU dependencies on critical space equipment and related technologies across their entire supply chain;Providing unrestricted access to critical space equipment and related technologies relevant for EU space missions;Developing or regaining capacity to operate independently in space by developing resilient critical space equipment and related technologies supply chains, relying on EU supply chains and/or trustable and reliable supply chains not affected by non-EU export restrictions;Enhancing competitiveness by developing products and capabilities reaching equivalent or superior performance level than those from outside the EU and compete at worldwide level;Opening new opportunities for manufacturers by reducing dependency on non-EU export...
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
43026
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Teriparatid, ATC H05AA02Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Diclofenac (ATC-Code nach WHO: D11AX18)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-31
43035
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-21 - Sofosbuvir, Velpatasvir, Voxilaprevir (Wirkstoffkombination)Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-31
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Naproxen/Esomeprazol (ATC-Code nach WHO: M01AE52)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-31
43038
Netherlands – Business services: law, marketing, consulting, recruitment, printing and security – DAS InhuurBuyer: Stichting Z-CERT | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-08-31
Tender
Procurement Contract
Netherlands
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Alitretinoin (ATC-Code nach WHO: D11AH04)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-31
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.11.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-VerfahrensBuyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-01
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Finland – Health and social work services – HenkilöstövuokrausBuyer: Pirkanmaan hyvinvointialue | Notice type: cn-social | Procedure: restricted | Contract: services | Deadline: 2027-09-01
Tender
Procurement Contract
Finland
Not provided on the source page. Please check the official source.
Space critical EEE components for EU non-dependenceExpected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic aut...
Research Funding
Cash Grant
Europe
Expected EU contribution: 250,000 EUR - 300,000 EUR
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic autonomy by reducing non-EU dependencies on critical space EEE components and related technologies across their entire supply chain;Providing unrestricted access to critical space EEE components and related technologies relevant for EU space missions;Developing or regaining capacity to operate independently in space by developing resilient space EEE components and related technologies supply chains, relying on EU supply chains and/or trustable and reliable supply chains not affected by non-EU export restrictions;Enhancing competitiveness by developing products and capabilities reaching equivalent or superior performance level than those from outside the EU and compete at worldwide level;Opening new opportunities for manufacturers by reducing dependency on non-EU...
43049
Quantum Space Gravimetry topicExpected Outcome:Projects are expected to contribute to the following outcomes:Support the EU space policy by fostering the develo...
Research Funding
Cash Grant
Europe
Expected EU contribution: 14,000,000 EUR - 15,000,000 EUR
Expected Outcome:Projects are expected to contribute to the following outcomes:Support the EU space policy by fostering the development of groundbreaking space technology and support the Quantum Europe Strategy.Enhance the technological maturation of the critical components necessary to perform quantum space gravimetry.Foster the technological leadership and non-dependence of the EU in the field of quantum gravimetry from space and promote the EU’s competitiveness in quantum technologies. This action aims at supporting the maturation, development and/or implementation of quantum gravimetry technology for space. Monitoring the Earth gravity field provides key information and data on Earth mass movements. This type of data is of utmost importance for Earth science and used in many areas, for example to monitor ice sheet changes, floods or droughts, volcanic activities and earthquakes. The...
43050
Space critical equipment for EU non-dependenceExpected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic aut...
Research Funding
Cash Grant
Europe
Expected EU contribution: 250,000 EUR - 300,000 EUR
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic autonomy by reducing non-EU dependencies on critical space equipment and related technologies across their entire supply chain;Providing unrestricted access to critical space equipment and related technologies relevant for EU space missions;Developing or regaining capacity to operate independently in space by developing resilient critical space equipment and related technologies supply chains, relying on EU supply chains and/or trustable and reliable supply chains not affected by non-EU export restrictions;Enhancing competitiveness by developing products and capabilities reaching equivalent or superior performance level than those from outside the EU and compete at worldwide level;Opening new opportunities for manufacturers by reducing dependency on non-EU export...
No saved opportunities on this page. Use the star icon near an opportunity title.
